Françoise Grudé - Concepedia

Author

Françoise Grudé

Also Known As

F Grude, F Grudé, F R Grude, F. Grude, F. Grudé, F. Grudé, Francoise Grude, Francoise Grudé, Françoise Grudé, Grude, Françoise

Publications

221

Citations

H-Index

Concepts

All Affiliations

Françoise Grudé is an author at Institut de Cancérologie de l'Ouest specializing in cancer research, medicine, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	109
2	Health Sciences	2	2	24
3	Gastroenterology	1	1	13
4	Health Policy	1	1	11
5	Nephrology	1	1	13

Françoise Grudé

Publications

125

Citations

H-Index

Page 1

	Year	Citations
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study Hugues Bourgeois, Françoise Grudé, P. Solal-Céligny, Annals of Oncology Prognostic AssessmentMedicineCancer ManagementPrognosisOutcomes Research	2017	47
PANERB study: Panitumumab after cetuximab-based regimen failure. J-P. Metges, Jean‐Luc Raoul, Nacredine Achour, Journal of Clinical Oncology Panerb StudyMedicineCancer ManagementE14000 BackgroundPathology	2010	38
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years Emmanuelle Jacquet, Ghania Kerouani‐Lafaye, Françoise Grudé, European Journal of Cancer	2021	16
Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer. Jean Philippe Metges, Jean François Ramée, Jean‐Yves Douillard, Journal of Clinical Oncology Surgical OncologyCancer ManagementGastroenterologyPathologyPharmacotherapy	2014	13
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019 Fiona Y.‐V. Pham, Emmanuelle Jacquet, Amina Taleb, International Journal of Cancer Therapeutic BenefitTemporary AuthorizationSolid TumorsCancer ManagementCancer Registration	2022	11

Page 1